In this retrospective, multicenter study, we evaluated the real-life outcomes of adult Philadelphia-positive acute lymphoblastic leukemia patients. The best results in terms of survival are achieved in patients who were treated with tyrosine kinase inhibitors during induction and received allogeneic hematopoietic cell transplantation as part of consolidation
This study aimed to determine the impact of tyrosine-kinase inhibitors given pre- and post-allogenei...
AbstractThe prognosis for adult and pediatric patients with Philadelphia chromosome-positive (Ph+) a...
We performed a nationwide registry-based analysis to describe the clinical outcome of adult patients...
In this retrospective, multicenter study, we evaluated the real-life outcomes of adult Philadelphia-...
In this retrospective, multicenter study, we evaluated the real-life outcomes of adult Philadelphia-...
BACKGROUND: The prognosis of Philadelphia-positive acute lymphoblastic leukemia (Ph(+) ALL) is gener...
In this retrospective, multicenter study, we evaluated the real-life outcomes of adult Philadelphia-...
From 1994 to 2000, 154 adults with Philadelphia chromosome-positive (Ph(+)) and/or BCR-ABL(+) acute ...
Adult Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph1-positive ALL) represents ab...
From 1994 to 2000, 154 adults with Philadelphia chromosome-positive (Ph+) and/or BCR-ABL(+) acute ly...
for the Groupe d’Etude et de Traitement de la Leucémie Aigue ̈ Lymphoblastique de l’Adulte (GET-LAL...
Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL) is the most common subtype o...
Philadelphia chromosome positive (Ph+) acute lympho-blastic leukemia (ALL) includes at least one-qua...
This study aimed to determine the impact of tyrosine kinase inhibitors given pre- and post-allogenei...
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acut...
This study aimed to determine the impact of tyrosine-kinase inhibitors given pre- and post-allogenei...
AbstractThe prognosis for adult and pediatric patients with Philadelphia chromosome-positive (Ph+) a...
We performed a nationwide registry-based analysis to describe the clinical outcome of adult patients...
In this retrospective, multicenter study, we evaluated the real-life outcomes of adult Philadelphia-...
In this retrospective, multicenter study, we evaluated the real-life outcomes of adult Philadelphia-...
BACKGROUND: The prognosis of Philadelphia-positive acute lymphoblastic leukemia (Ph(+) ALL) is gener...
In this retrospective, multicenter study, we evaluated the real-life outcomes of adult Philadelphia-...
From 1994 to 2000, 154 adults with Philadelphia chromosome-positive (Ph(+)) and/or BCR-ABL(+) acute ...
Adult Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph1-positive ALL) represents ab...
From 1994 to 2000, 154 adults with Philadelphia chromosome-positive (Ph+) and/or BCR-ABL(+) acute ly...
for the Groupe d’Etude et de Traitement de la Leucémie Aigue ̈ Lymphoblastique de l’Adulte (GET-LAL...
Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL) is the most common subtype o...
Philadelphia chromosome positive (Ph+) acute lympho-blastic leukemia (ALL) includes at least one-qua...
This study aimed to determine the impact of tyrosine kinase inhibitors given pre- and post-allogenei...
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acut...
This study aimed to determine the impact of tyrosine-kinase inhibitors given pre- and post-allogenei...
AbstractThe prognosis for adult and pediatric patients with Philadelphia chromosome-positive (Ph+) a...
We performed a nationwide registry-based analysis to describe the clinical outcome of adult patients...